It is a World Arthritis Day initiative to raise awareness on knee osteoarthritis
On the eve of World Arthritis Day 2014, Bhaichung Bhutia, former captain of India’s football team, joined healthcare major Sanofi India’s ‘Steps that Count’ initiative to raise awareness on knee osteoarthritis. The initiative encourages patients to live well with osteoarthritis by following the three important steps of Talk- Control- Exercise.
According to Dr Karthik Pingle, Consultant Orthopedic Surgeon, Apollo Jubilee Hills, Hyderabad, “After diabetes, osteoarthritis is considered the second most prevalent disease in the age group of 30-55 years. Of all the joints, osteoarthritis of the knee joint is the most common. A number of factors such as sedentary lifestyle, rising obesity and poor dietary habits contribute to the high prevalence of knee osteoarthritis.”
Speaking on the occasion Dr Senthilnathan Mohanasundaram, Director- Medical Affairs, Sanofi India stated, “With over 15 million patients, India has the second largest osteoarthritis patient base– women forming a large portion of this population. We are delighted to have Bhaichung Bhutia support Sanofi’s ‘Steps that Count’ initiative that aims to raise awareness on knee osteoarthritis among young arthritic patients (30-55 years age). Bhaichung’s testimonial and experience with viscosupplementation will motivate patients to explore treatment options with their specialists and lead an active and better quality life.”
Depending upon the grade of knee osteoarthritis, treatment options include a combination of exercise, a healthy diet, painkillers, viscosupplementation injections as well as surgical procedures to relieve pain and restore function.
Dr Sachin Yadav, Orthopedics & Sports Medicine Consultant, Skyline Hospital & Ayushman Hospital, Delhi, and Bhaichung Bhutia’s treating physician shared, “I have found viscosupplementation to be an effective option for young active individuals such as Bhaichung Bhutia as it enables them to maintain their active lifestyles. This is supported by the recently published Osteoarthritis Synvisc One Indian Post Marketing Study (OASIS) which concluded that viscosupplementation with Synvisc One was well tolerated and effective in reducing knee pain in an osteoarthritis patient with a significant long-term (1 year) improvement of outcomes.”
EH News Bureau